CYTUnknown
Cyteir Therapeutics, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Cyteir Therapeutics, Inc. (CYT), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are CYT insiders buying or selling?
Cyteir Therapeutics, Inc. insiders reported 12 open-market buys ($16.0M) and 8 sells ($3.8M) across 20 Form 4 filings — a net buying position of $12.3M.
Source: SEC EDGAR Form 4
Key Statistics (as of Mar 25, 2024)
Total Form 4 filings
20
SEC EDGAR
Insider filers
6
Insider buys (12)
$16.0M
Insider sells (8)
$3.8M
Insider sentiment
Net buyingNet insider flow of $12.3M in net buying.
Recent CYT insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mar 25, 2024 | Braden Michael Leonard | 10% Owner | Purchase | 170.6K | $2.95 | $503.2K |
| Mar 19, 2024 | Braden Michael Leonard | 10% Owner | Purchase | 113.8K | $3.01 | $342.5K |
| Jul 21, 2023 | Novo Holdings A/S | 10% Owner | Sale | 101.9K | $2.75 | $280.4K |
| Jul 19, 2023 | Novo Holdings A/S | 10% Owner | Sale | 38.6K | $2.75 | $106.0K |
| Jul 3, 2023 | Novo Holdings A/S | 10% Owner | Sale | 200.9K | $2.63 | $529.3K |
| Jun 29, 2023 | Novo Holdings A/S | 10% Owner | Sale | 40.4K | $1.78 | $71.8K |
| Jun 23, 2023 | Novo Holdings A/S | 10% Owner | Sale | 13.3K | $1.95 | $25.9K |
| Jun 20, 2023 | Novo Holdings A/S | 10% Owner | Sale | 16.7K | $2.03 | $34.0K |
| Jun 15, 2023 | Novo Holdings A/S | 10% Owner | Sale | 6.4K | $2.10 | $13.4K |
| Dec 8, 2022 | Joseph S Zakrzewski | Director | Purchase | 21.2K | $1.30 | $27.6K |
| Jul 22, 2022 | Novo Holdings A/S | 10% Owner | Sale | 900.0K | $3.00 | $2.7M |
| May 16, 2022 | Joseph S Zakrzewski | Director | Purchase | 743 | $1.61 | $1.2K |
| May 12, 2022 | John F Thero | Director | Purchase | 10.0K | $2.00 | $20.0K |
| May 12, 2022 | Joseph S Zakrzewski | Director | Purchase | 50.4K | $1.89 | $95.1K |
| Dec 28, 2021 | Joseph S Zakrzewski | Director | Purchase | 1.1K | $9.91 | $10.9K |
| Dec 21, 2021 | Joseph S Zakrzewski | Director | Purchase | 200 | $9.88 | $2.0K |
| Dec 16, 2021 | Joseph S Zakrzewski | Director | Purchase | 3.7K | $10.77 | $39.8K |
| Jun 25, 2021 | Luc Verelst | 10% Owner | Purchase | 277.8K | $18.00 | $5.0M |
| Jun 25, 2021 | Janwillem Naesens | Director | Purchase | 277.8K | $18.00 | $5.0M |
| Jun 23, 2021 | Novo Holdings A/S | 10% Owner | Purchase | 277.8K | $18.00 | $5.0M |
Showing the 20 most recent of 20 Form 4 filings for Cyteir Therapeutics, Inc..
Most active CYT insiders
- Novo Holdings A/S9 filings
- Joseph S Zakrzewski6 filings
- Braden Michael Leonard2 filings
- Luc Verelst1 filing
- Janwillem Naesens1 filing
Ask anything about CYT insider activity
Use Trabud's AI agent to query Cyteir Therapeutics, Inc.'s Form 4 history in plain English — "Show me CYT CEO purchases this year" or compare it against any other ticker.
Open the AI agentCYT insider trading FAQ
Are Cyteir Therapeutics, Inc. insiders buying or selling?
Across 20 SEC Form 4 filings, Cyteir Therapeutics, Inc. (CYT) insiders reported 12 open-market purchases totaling $16.0M and 8 sales totaling $3.8M. That is a net buying position of $12.3M.
How many insiders trade CYT stock?
6 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Cyteir Therapeutics, Inc.. The most recent filing was accepted on Mar 25, 2024.
Where does Trabud get CYT insider trading data?
All CYT insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.